You are here
Temasek unit pares stakes in S Korean pharma firms for as much as S$1.36b
TEMASEK Holdings' unit Ion Investments on Wednesday said it is paring its stakes in two South Korean pharmaceutical companies but will remain a substantial shareholder in both.
Earlier on Tuesday, IFR reported that Ion is selling part of its stakes in Celltrion Inc, and
- CALL +65 6388 3838
- EMAIL email@example.com